Bringing Rare Disease Drugs to Canada: Opportunities, Challenges, and More Challenges
The session will be moderated by 3Sixty Public Affairs’ Bill Dempster, who will be joined by several Canadian experts in pharmaceutical access, including a former director of the Ontario Public Drug Programs.
This discussion will review the current state of pubic reimbursement for orphan medicines and examine how the emerging discussions about a new national pharmacare program will affect patient access to these medicines. The session will be followed by an interactive question and answer session. This webinar will be an interactive live webcast from the Canadian Organization for Rare Disorders’ Rare Disease Day event in Ottawa.